| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.6 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.093 | 0.6 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |